Table Multiple Myeloma Trials November 2024
Miles Matter: The Geographic Disparity That Impacts Access to CAR T Therapy
Wave of Antibody-Drug Conjugates Poised to Change Treatment Paradigms Across Multiple Cancers
Health Care Practitioners Push for Legislative Solution to Prevent Chemotherapy Shortage “Groundhog Day”
From CAR T’s “Wait List Mortality” to “Tethering” Bispecific Antibodies, Oncologists Navigate Time-Sensitive Sequencing in Multiple Myeloma
Navigating Decision-Making When Treating Lymphoma With Bispecific Antibodies vs CAR T-Cell Therapy
